Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
≥72% 7...8 aastastest uuritavatest.
≥72% of subjects 7-8 years of age.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vereülekannet ei saanud ükski uuritavatest.
no subject received a blood transfusion.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
valitav protseduur sõltub uuritavatest aminohapetest.
the procedure chosen depends on the amino acids under investigation.
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
kõik raviga seotud kõrvalnähud ≥ 5% uuritavatest.
all treatment-emergent adverse events with ≥ 5% of subjects
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
juhtum tekkis vähem kui pooltel ohustatud uuritavatest.
fewer than half of at-risk subjects had an event.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kõikides vanuserühmades teatati palavikust vähesel protsendil uuritavatest.
across all ages, low percentages of subjects reported fever.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
südame paispuudulikkust täheldati 0,5 % uuritavatest kummaski ravirühmas.
congestive heart failure was observed in 0.5% of subjects in each treatment arm.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kokku 54%-l uuritavatest oli ravieelselt vähem kui 3 haiguskollet.
overall, 54% of subjects had <3 disease sites at baseline.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
kõik raviga seotud tõsised kõrvalnähud 1% lenalidomiidiga ravitud uuritavatest
all treatment-emergent serious adverse events in 1% of lenalidomide treated subjects
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
korea valitsuse ja citibanki korral ulatusid need kaugemale uuritavatest laenudest.
for the gok and citibank these went beyond the loans investigated.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
umbes ühel protsendil uuritavatest toimus losartaani minimaalne konversioon aktiivseks metaboliidiks.
minimal conversion of losartan to its active metabolite was seen in about one percent of individuals studied.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
düspnoest teatati ligikaudu 30% uuritavatest kyprolis’e kliinilistes uuringutes.
dyspnoea was reported in approximately 30% of subjects in clinical studies with kyprolis.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
reas farmakokineetilistes ja kliinilistes uuringutes saavutasid 6% uuritavatest kõrgema desloratadiini kontsentratsiooni.
in a series of pharmacokinetic and clinical trials, 6% of the subjects reached a higher concentration of desloratadine.
Last Update: 2012-04-11
Usage Frequency: 5
Quality:
uuritavatest ainetest valmistatakse vajaliku kontsentratsiooniga vesilahused, kuhu ei tohi jääda lahustumatut jääki.
aqueous solutions shall be prepared of the substances to be tested, using the required concentrations in water, and shall not contain any non-dissolved substances.
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
skisofreenia kliinilistes uuringutes täheldati invega puhul seerumi prolaktiinisisalduse suurenemist 67% uuritavatest.
in schizophrenia clinical trials, increases in serum prolactin were observed with invega in 67% of subjects.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tehti kindlaks, et uurimisperioodi jooksul kasutase seda kava üks uuritavatest eksportijatest, kes tegutses gujaratis.
it was established that one exporter under investigation, which is situated in gujarat, used this scheme during the review investigation period.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
alfaepoetiiniga ravitud ≥ 1% uuritavatest esinenud kõrvaltoimed neis uuringutes on toodud allolevas tabelis.
adverse drug reactions reported by ≥ 1% of subjects treated with epoetin alfa in these trials are shown in the table below.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ligikaudu 40%-l ravitud uuritavatest esines süsteemseid kõrvalnähte ja ligikaudu 54%-l reaktsioone süstekohal.
approximately 40% of treated subjects experienced systemic adverse reactions and approximately 54% experienced injection site reactions.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
mõningate ühendite puhul võib suure kontsentratsiooniga uuritavatest doosidest keeldumine põhjustada selle, et toitu tarbitakse vähe või üldse mitte.
for some compounds, at higher concentrations rejection of test dose may result in little or no food being consumed.
vaktsiinigrupis olid kolmanda annuse manustamise järgse kuu jooksul muutunud kõikidele vaktsiini serotüüpidele seropositiivseks 99,1 kuni 100% uuritavatest.
in the vaccine group, 99.1 to 100% became seropositive to all vaccine serotypes by 1 month postdose 3.